Sajni Josson, Ph.D.
Affiliations: | 2006 | University of Kentucky, Lexington, KY |
Area:
Toxicology, RadiologyGoogle:
"Sajni Josson"Parents
Sign in to add mentor| Daret S. Clair | grad student | 2006 | University of Kentucky | |
| (Role of RelB in radiation resistance and tumorigenicity of prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chu GC, Chung LWK, Gururajan M, et al. (2019) Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian Journal of Urology. 6: 65-81 |
| Josson S, Gururajan M, W K Chung L. (2017) miRNA Characterization from the Extracellular Vesicles. Bio-Protocol. 7: e2139 |
| Josson S, Chung LW, Gururajan M. (2015) microRNAs and Prostate Cancer. Advances in Experimental Medicine and Biology. 889: 105-18 |
| Gururajan M, Cavassani KA, Sievert M, et al. (2015) SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Oncotarget |
| Josson S, Gururajan M, Sung SY, et al. (2015) Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 34: 2690-9 |
| Gururajan M, Josson S, Chu GC, et al. (2014) miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6559-69 |
| Josson S, Gururajan M, Hu P, et al. (2014) miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4636-46 |
| Nomura T, Huang WC, Zhau HE, et al. (2014) β2-Microglobulin-mediated signaling as a target for cancer therapy. Anti-Cancer Agents in Medicinal Chemistry. 14: 343-52 |
| Li X, Chen YT, Josson S, et al. (2013) MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells. Plos One. 8: e70987 |
| Josson S, Matsuoka Y, Gururajan M, et al. (2013) Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cells. Plos One. 8: e68366 |